drugset / Trial / NCT04037527
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Phase 1
Terminated
9 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this Phase 1 research study is to obtain data or information on the safety and effectiveness of the combination of gemcitabine, docetaxel with radiation.
Timeline
- Start
- 2020-08-18
- Primary completion
- 2024-06-18
- Completion
- 2024-06-18
Outcome
Outcome not reported
Stopped: “Terminated due DLTs”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 10 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 25 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 100 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 300 mg/m2 | — |